Clarius Group LLC Purchases 247 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Clarius Group LLC increased its position in HCA Healthcare, Inc. (NYSE:HCA) by 19.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,540 shares of the company’s stock after buying an additional 247 shares during the quarter. Clarius Group LLC’s holdings in HCA Healthcare were worth $462,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the business. FMR LLC increased its holdings in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Darsana Capital Partners LP lifted its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the period. Meritage Group LP bought a new position in HCA Healthcare during the 3rd quarter worth approximately $150,548,000. Canoe Financial LP increased its position in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after buying an additional 231,492 shares during the period. Finally, Holocene Advisors LP boosted its position in HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after acquiring an additional 208,015 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $310.60 on Monday. HCA Healthcare, Inc. has a 52-week low of $278.50 and a 52-week high of $417.14. The company has a 50-day simple moving average of $316.69 and a 200 day simple moving average of $353.01. The company has a market capitalization of $78.68 billion, a PE ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Oppenheimer boosted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Barclays reduced their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Finally, Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.